Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

NCT04380740 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Graft Vs Host Disease

Interventions

DRUG: Placebo
DRUG: Abatacept

Sponsor

Boston Children's Hospital

Collaborators

[object Object]